Chukwuebuka Richard Obiora | Nanomedicine | Best Researcher Award

Published on by Global Scholar Awards

Mr. Chukwuebuka Richard Obiora | Nanomedicine | Best Researcher Award

Senior Research Technician at CPI (Centre for Process Innovation), United Kingdom

Richard Obiora is a highly motivated and results-oriented Senior Research Technician with over 3 years of experience in drug delivery systems, including RNA-LNP therapeutics, polymeric nanoparticles, and microneedles. He has demonstrated technical expertise in nanoparticle characterization techniques such as particle sizing and zeta potential, and has contributed to drug delivery applications in vaccines and chemotherapy. His experience spans both academic and industrial settings, including his roles at CPI (Centre for Process Innovation) and Reckitt Benckiser. Richard is known for his ability to troubleshoot complex issues, collaborate effectively, and implement innovative solutions to enhance efficiency. While his early career lacks a strong record of independent publications and extensive leadership in research projects, his work in emerging fields like nanomedicine and RNA therapeutics shows significant promise. With further development in his research independence and publication record, Richard is a strong candidate for future awards and recognition.

Professional Profile 

Education🎓

Richard Obiora’s educational background includes a solid foundation in pharmaceutical and chemical sciences. He completed his undergraduate studies with a focus on biochemistry and pharmaceutical sciences, which provided him with the necessary technical knowledge to pursue advanced research in drug delivery systems. His academic journey was further strengthened through his internship at the University of Strathclyde, where he worked on synthesizing and characterizing polymeric nanoparticle-protein interactions for nanomedicine applications. This project allowed him to apply cutting-edge techniques, such as Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA), to study the formation of protein corona and its effects on nanoparticle cellular uptake. His education has been complemented by hands-on experience in the research and development sector, which has contributed to his technical skill set and ability to collaborate on multidisciplinary research projects. This combination of academic and practical experience has shaped Richard into a well-rounded and knowledgeable researcher.

Professional Experience📝

Richard Obiora has accumulated diverse professional experience across both academic and industrial settings. Currently, as a Senior Research Technician at the Centre for Process Innovation (CPI) in the UK, he works as part of the Nanopharmaceutical team, focusing on encapsulating active pharmaceutical ingredients, such as RNA, into nanoparticles like LNPs and polymeric systems for drug delivery applications. His work includes critical tasks such as particle characterization using techniques like zeta potential and particle sizing, as well as managing downstream processing and filtration for sterilizing nanoparticle-loaded drugs. Prior to this, Richard served as a Research & Development Assistant at Reckitt Benckiser, where he contributed to developing environmentally friendly formulations for products like solar-powered Air Wick air fresheners. Additionally, he gained valuable experience during an internship at the University of Strathclyde, where he worked on characterizing nanoparticle-protein interactions for nanomedicine, further developing his skills in nanoparticle synthesis and analysis.

Research Interest🔎

Richard Obiora’s research interests lie in the development of advanced drug delivery systems, particularly focusing on nanomedicine and nanoparticle-based technologies. He is deeply involved in the encapsulation of active pharmaceutical ingredients, such as RNA, into nanoparticles like lipid nanoparticles (LNPs) and polymeric systems, with a specific emphasis on their application in vaccines and chemotherapy. His work includes studying the behavior of nanoparticles in biological systems, including their stability, particle size, and surface charge, using various analytical techniques such as Dynamic Light Scattering (DLS) and nanoparticle tracking analysis (NTA). Richard is also interested in optimizing drug delivery systems to improve therapeutic efficacy while minimizing side effects, which has significant implications for treatments in oncology and immunology. Additionally, his past research at the University of Strathclyde, focusing on polymeric nanoparticle-protein interactions, reflects his interest in understanding how nanoparticle formulations can interact with biological environments to enhance cellular uptake and improve therapeutic outcomes.

Award and Honor🏆

As of now, Richard Obiora has not been explicitly recognized with major awards or honors in his career. However, his professional trajectory reflects a strong foundation of excellence and dedication within the research field. His work at the Centre for Process Innovation (CPI), where he plays a key role in advancing nanomedicine, particularly RNA-LNP therapeutics, demonstrates his commitment to pioneering scientific developments. Richard’s ability to troubleshoot complex technical issues and lead tasks within larger projects has been instrumental in driving innovative solutions within the field of drug delivery systems. His research contributions, particularly in the synthesis, characterization, and application of nanoparticles, are highly relevant to the future of biomedical therapies, positioning him as a promising candidate for future awards and recognition. His ongoing work in nanomedicine, coupled with his cross-industry experience, suggests that Richard is well on his way to achieving significant professional milestones and recognition in the coming years.

Research Skill🔬

Richard Obiora possesses a robust set of research skills, particularly in the field of nanomedicine and drug delivery systems. He is highly skilled in nanoparticle synthesis, encapsulation techniques, and the application of various nanoparticles, such as lipid nanoparticles (LNPs) and polymeric systems, for therapeutic purposes. Richard excels in utilizing advanced characterization methods like Dynamic Light Scattering (DLS), Zetasizer, and Nanoparticle Tracking Analysis (NTA) to analyze particle size, zeta potential, and stability of drug formulations. His proficiency in techniques such as SDS-PAGE, resonance mass measurement, and Bradford/BCA assays reflects his strong analytical capabilities. Richard also has experience in downstream processing and filtration for sterilization and improving the efficiency of drug delivery systems. His research skills are complemented by a solid understanding of pharmaceutical sciences, enabling him to troubleshoot complex issues and innovate solutions to enhance the effectiveness and safety of drug delivery systems.

Conclusion💡

Richard Obiora is a very promising researcher with strong technical expertise, innovation skills, and a focused research background in highly impactful areas like RNA-LNP therapeutics and nanomedicine.
However, for a “Best Researcher Award,” which usually recognizes candidates with a substantial record of independent research, publications, and broader impact, Richard may still be in an early career stage.

Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Published on by Global Scholar Awards

Prof. Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Professor and Deputy Registrar at Anurag University, India

Dr. Padmanabha Rao Amarachinta, Professor and Deputy Registrar at Anurag University, Hyderabad, is a distinguished scholar in pharmaceutical sciences with over 23 years of experience in teaching, research, and industry. He holds a Ph.D. in Toxicology and has conducted advanced research at premier Indian institutions like IICT, CCMB, and NIN. Dr. Rao has published over 35 high-impact papers and authored several book chapters, notably in the area of nanomedicine. His innovations in drug delivery systems, particularly intranasal delivery of Rizatriptan, have earned him both Indian and German patents. He is a recipient of numerous awards including the “Distinguished Scientist Award” and “Leading Educationist of India.” His research interests include nanotechnology, drug discovery, and clinical research, and he is actively involved in mentoring Ph.D. scholars. Dr. Rao’s impactful contributions and leadership in pharmaceutical research make him a strong candidate for the Leading Innovations in Science Award.

Professional Profile 

Education🎓

Dr. Padmanabha Rao Amarachinta possesses a strong academic background in pharmaceutical sciences, culminating in a Ph.D. in Toxicology. His educational journey laid a solid foundation for his research and teaching career, with a focus on drug delivery systems and nanomedicine. Throughout his academic training, Dr. Rao demonstrated a keen interest in toxicology and pharmacology, which guided his doctoral research and subsequent scientific contributions. His advanced studies were complemented by research collaborations with prestigious Indian institutes such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and the National Institute of Nutrition (NIN), where he further deepened his expertise in biomedical sciences. His academic achievements reflect a rigorous and interdisciplinary approach to science, combining theoretical knowledge with practical research applications. Dr. Rao’s educational foundation continues to influence his innovative work in pharmaceutical technology, toxicology, and clinical research, enabling him to mentor scholars and contribute to cutting-edge scientific advancements.

Professional Experience📝

Dr. Padmanabha Rao Amarachinta brings over 17 years of diverse professional experience in academia and research, specializing in pharmaceutical sciences and toxicology. He has held significant academic positions, notably serving as an Associate Professor in the Department of Pharmacy at GITAM Deemed to be University. Dr. Rao has been instrumental in designing and delivering advanced curricula in pharmacology and toxicology, mentoring postgraduate and Ph.D. scholars, and fostering a research-driven academic environment. His professional journey includes collaborative research projects with prestigious institutions such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and National Institute of Nutrition (NIN). He has contributed to numerous national and international journals, reflecting his strong research acumen. Dr. Rao’s career highlights his commitment to academic excellence, interdisciplinary research, and innovation in drug delivery systems, making him a respected figure in both academic and scientific communities.

Research Interest🔎

Dr. Padmanabha Rao Amarachinta’s research interests lie primarily in the fields of pharmacology, toxicology, and drug delivery systems, with a special focus on the evaluation of herbal and synthetic drugs for their therapeutic efficacy and safety. He is particularly interested in the pharmacodynamic and pharmacokinetic profiling of novel drug candidates, including natural products with potential pharmacological activity. Dr. Rao explores innovative drug delivery mechanisms to enhance the bioavailability and targeted action of therapeutic agents, aiming to reduce side effects and improve patient outcomes. His research also delves into preclinical toxicological evaluations and the mechanisms of drug-induced organ toxicity. He is passionate about bridging traditional medicinal knowledge with modern pharmacological approaches through scientific validation of herbal formulations. With collaborations across premier research institutions, his work contributes significantly to advancements in evidence-based medicine and the development of safer, more effective treatment options for chronic and acute conditions.

Award and Honor🏆

Dr. Padmanabha Rao Amarachinta has received numerous awards and honors in recognition of his outstanding contributions to pharmaceutical sciences and academic excellence. He has been honored with prestigious fellowships and accolades from reputed institutions, highlighting his dedication to research and innovation in pharmacology and toxicology. Among his notable recognitions are awards for best research paper presentations at national and international conferences, acknowledging the scientific impact and quality of his work. He has also received institutional awards for his commitment to teaching and mentoring students, fostering a collaborative and intellectually stimulating academic environment. His contributions to the field have earned him invitations to serve as a keynote speaker and session chair at several scientific events. These honors reflect not only his professional achievements but also his influence in shaping the next generation of researchers and healthcare professionals, reinforcing his status as a respected figure in the pharmaceutical and biomedical research community.

Research Skill🔬

Dr. Padmanabha Rao Amarachinta possesses a comprehensive set of research skills that span across pharmaceutical sciences, pharmacology, and toxicology. His expertise lies in experimental design, data analysis, and interpretation, particularly in preclinical and in vitro models used for drug evaluation and safety profiling. He is highly skilled in molecular biology techniques, including PCR, ELISA, and Western blotting, which he employs in elucidating mechanisms of drug action and toxicity. Dr. Amarachinta is adept at handling laboratory instruments and software for statistical and bioinformatics analysis, facilitating accurate and reproducible research outcomes. His ability to draft scientific manuscripts, research proposals, and grant applications showcases his proficiency in academic writing and communication. Additionally, he has guided numerous postgraduate students, demonstrating his capability in mentoring and collaborative research. His methodical approach, critical thinking, and problem-solving abilities significantly contribute to his success in advancing pharmaceutical research and generating impactful scientific knowledge.

Conclusion💡

Dr. Padmanabha Rao Amarachinta exhibits strong qualifications for the Leading Innovations in Science Award. His deep-rooted contributions in nanomedicine, high-impact publications, international patents, and academic leadership make him a compelling nominee. He is a proven innovator in pharmaceutical sciences with an impressive blend of academic, research, and administrative excellence.

With minor emphasis on commercialization, global project leadership, and science communication, his already remarkable portfolio could be elevated to even greater heights.

Publications Top Noted✍️

  • Title: Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect
    Authors: PR Amarachinta, G Sharma, N Samed, AK Chettupalli, M Alle, JC Kim
    Year: 2021
    Citations: 77

  • Title: Design, formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel
    Authors: AK Chettupalli, M Ananthula, PR Amarachinta, V Bakshi, VK Yata
    Year: 2021
    Citations: 51

  • Title: Pharmacological evaluation of herbal extracts for their in-vitro hypoglycemic activity
    Authors: AP Rao, KJ Kaiser Jamil
    Year: 2011
    Citations: 32

  • Title: Comparative toxicity of tetra ethyl lead and lead oxide to earthworms, Eisenia fetida (Savigny)
    Authors: JV Rao, P Kavitha, AP Rao
    Year: 2003
    Citations: 24

  • Title: Design, development and optimization of solid lipid nanoparticles of rizatriptan for intranasal delivery: in-vitro & in-vivo assessment
    Authors: V Bakshi, PR Amarachinta, AK Chettupalli
    Year: 2022
    Citations: 23

  • Title: Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: Statistical optimization and pharmacological evaluations
    Authors: A Unnisa, AK Chettupalli, RS Alazragi, W Alelwani, AM Bannunah, …
    Year: 2023
    Citations: 17

  • Title: Development and validation of glibenclamide in nanoemulsion formulation by using RP-HPLC
    Authors: AB Mohd, P Swathimutyam, AP Rao, N Shastri, PV Diwan
    Year: 2011
    Citations: 15

  • Title: Method development and validation for estimation of risperidone in novel liquisolid formulation by RP-HPLC
    Authors: K Sanka, S Bairi, R Gullapelli, S Bandi, AM Babu, AP Rao, PV Divana
    Year: 2014
    Citations: 9

  • Title: Formulation and evaluation of poly herbal liqui-solid compact for its anti-inflammatory effect
    Authors: AK Chettupalli, RR Amara, PR Amarachinta, RM Manda, BSR Garige, …
    Year: 2021
    Citations: 8

  • Title: Development and validation of simvastatin in microemulsion formulation using RP-HPLC
    Authors: C Srinivas, AB Mohd, S Huidrom, A Rao, PV Diwan
    Year: 2012
    Citations: 8

  • Title: Quality by Design approach for preparation, characterization, and statistical optimization of naproxen sodium-loaded ethosomes via transdermal route
    Authors: AK Chettupalli, S Ajmera, PR Amarachinta, RM Manda, RK Jadi
    Year: 2023
    Citations: 6

  • Title: Preclinical evaluation of polyherbal formulations: hypoglycemic activity in rats
    Authors: PR Amarachinta, KJ Kaiser Jamil
    Year: 2012
    Citations: 6

  • Title: Letter to Editor: Recent Advancement in Blood Cancer Research and Management
    Authors: MA Jahangir, AP Rao
    Year: 2019
    Citations: 4